Kriya Announces More Than $430 million Series C Financing Round

Palo Alto – July 26, 2023 – Cooley advised Kriya, a biopharmaceutical company, on the addition of over $150 million in capital committed as part of its Series C financing, bringing the total Series C financing round to more than $430 million. Since its founding in October 2019, Kriya has raised over $600 million in committed capital – and with this financing, Kriya’s cash runway is anticipated to run into late 2026. Lawyers Lauren Creel, Lindsy Solanki and Kristina Krasnikova led the Cooley team.

Proceeds from the financing will support the clinical translation of Kriya’s broad pipeline of gene therapies, as well as continued scaling of its engineering, computational and manufacturing platforms.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.